- Current report filing (8-K)
26 August 2010 - 8:37PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
FORM
8-K
|
CURRENT
REPORT
|
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Date
of Report (Date of earliest event reported)
|
August 24, 2010
|
|
Kewaunee
Scientific Corporation
(Exact
name of registrant as specified in its
charter)
|
|
|
|
Delaware
|
0-5286
|
38-0715562
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File
Number)
|
(I.R.S.
Employer
Identification
No.)
|
2700
West Front Street
Statesville,
North Carolina
(Address
of principal executive offices)
|
28677
(Zip
Code)
|
Registrant’s
telephone number, including area
code 704-873-7202
|
|
N/A
(Former
name or former address, if changed since last report.)
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 2.02 Results
of Operations and Financial Conditions
On August
24, 2010, Kewaunee Scientific Corporation issued a press release announcing its
financial results for the first quarter ended July 31, 2010. A copy
of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form
8-K.
Item 9.01 Financial
Statements and Exhibits
(d)
Exhibits:
Exhibit
No.
99.1 Press
Release of Kewaunee Scientific Corporation dated August 24, 2010.
In
accordance with General Instruction B.2 of Form 8-K, the information in this
Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), or otherwise subject to the liabilities of that section,
and shall not be incorporated by reference into any registration statement or
other document filed under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in
such filing.
Signature
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
(Registrant)
|
|
|
|
Kewaunee
Scientific Corporation
|
|
|
|
|
Date: August
24, 2010
|
|
|
/s/
D. Michael Parker
|
|
|
|
D.
Michael Parker
Senior
Vice President, Finance
|
|
|
|
Chief
Financial Officer
|
Kewaunee Scientific (NASDAQ:KEQU)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Kewaunee Scientific (NASDAQ:KEQU)
Historical Stock Chart
Von Jul 2023 bis Jul 2024